
Loading, please wait...

Loading, please wait...

Post-stroke cognitive impairment (PSCI) remains a significant contributor to dementia among survivors in India and worldwide. Consequently, clinicians require advanced tools for early PSCI risk prediction to implement timely interventions. Researchers recently introduced a robust multimodal machine learning model to bridge this clinical gap. This model integrates clinical, demographic, and neuroimaging data from acute ischemic stroke (AIS) patients. By employing a stacking ensemble approach, it successfully identifies individuals at risk of cognitive decline within three to six months post-stroke.
The study evaluated 1070 AIS patients and utilized six sophisticated base algorithms, including XGBoost, CatBoost, and Support Vector Machines. A meta-model then processed these individual outputs to generate a highly accurate final risk score. Consequently, the stacking model achieved a remarkable internal accuracy of 98.13% and an AUC of 0.9972. External validation also demonstrated strong performance, yielding an AUC of 0.9049. Importantly, the analysis identified that infarct volume and baseline NIHSS scores are among the strongest predictors of subsequent cognitive impairment.
Furthermore, neuroimaging features played a critical role in the predictive success of the model. Specific indicators, such as medial temporal lobe atrophy and the presence of cortical lesions, significantly improved risk stratification. Therefore, integrating multimodal data provides a much more comprehensive view of a patient's recovery trajectory than traditional methods. This approach facilitates the development of personalized intervention strategies. Ultimately, early detection through artificial intelligence can help healthcare providers prevent the progression from acute stroke to long-term post-stroke dementia.
The most significant predictors include infarct volume, cortical lesions, and the baseline NIHSS score. Additionally, medial temporal lobe atrophy serves as a key neuroimaging marker for identifying high-risk patients during the acute phase.
A stacking model combines the strengths of multiple base algorithms into one meta-model. Consequently, it reduces individual model bias and improves overall robustness. This technique ensures more reliable predictions across diverse patient populations compared to single-algorithm approaches.
Standard practice involves assessing cognitive function three to six months post-stroke. However, using predictive machine learning models during initial hospitalization allows for earlier identification and proactive management planning for high-risk individuals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Zheng X et al. Multimodal machine learning for early risk stratification of post-stroke cognitive impairment. J Alzheimers Dis. 2026 May 30. doi: 10.1177/13872877261454538. PMID: 42216673.
2. de Filippis R and Al Foysal A. Deep Learning for Predicting Post-Stroke Cognitive Decline Using Multimodal Data. Open Access Library Journal. 2026;13:1-22. doi: 10.4236/oalib.1114446.
3. BMJ Open. Prevalence and risk factors of cognitive impairment among stroke survivors in India: an analysis of cross-sectional data from the Longitudinal Ageing Study in India. 2026;16:e072145.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A multimodal stacking ensemble model predicts post-stroke cognitive impairment (PSCI) with high accuracy by integrating clinical and neuroimaging data....
4 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today